SOFIE is combining the discovery and development of new PET imaging probes with innovative imaging systems and chemistry platforms to provide researchers and physicians with tools to better understand the biology of disease. By empowering a wide array of people with valuable, translational imaging systems and probes, SOFIE is aimed toward making PET imaging more accessible and increasing the diversity of its applications.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/15/13 | $5,000,000 | Series A |
Cycad Group MRM Capital Tata Industries | undisclosed |
